Results 191 to 200 of about 5,070,890 (303)

One century of teaching, research, and innovation in chemical engineering in Mexico: The role of chemical engineering in the background and future of polymer science and industrial production in Mexico

open access: yesThe Canadian Journal of Chemical Engineering, EarlyView.
Timeline of key academic milestones and individuals that shaped chemical engineering at FQ‐UNAM and in Mexico. Abstract One hundred years after the beginning of the teaching of Chemical Engineering in Mexico, which started in 1925 in the former National School of Chemical Sciences, currently Faculty of Chemistry (FQ) at National Autonomous University ...
Patricia Pérez‐Salinas   +2 more
wiley   +1 more source

One hundred years of teaching, research, and innovation in chemical engineering at the Faculty of Chemistry, National Autonomous University of Mexico (UNAM): Birthplace and enduring leadership of the discipline in Mexico

open access: yesThe Canadian Journal of Chemical Engineering, EarlyView.
The teaching of chemical engineering in Mexico started in 1925 at the Faculty of Chemistry (FQ) of the National Autonomous University of Mexico (UNAM). Academic institutions, research centres, chemical companies, technological developments, highly trained personnel, and scientific contributions are part of the legacy from FQ‐UNAM.
Patricia Pérez‐Salinas   +4 more
wiley   +1 more source

The life and work of Ernest Sydney Keeping

open access: yesCanadian Journal of Statistics, EarlyView.
Abstract This article reviews the life and contributions of Ernest S. Keeping (1895–1984), a British‐born physicist who became a mathematics professor at the University of Alberta in 1929. He played a pivotal role in shaping the university's Mathematics Department, serving as its head from 1954 to 1961, and continuing to teach until 1970, nine years ...
David R. Bellhouse, Christian Genest
wiley   +1 more source

Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy